Targeted Radionuclide Therapy
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relat...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2011-10-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6694/3/4/3838/ |
| _version_ | 1797727390168776704 |
|---|---|
| author | David Cheng Devrim Ersahin Indukala Doddamane |
| author_facet | David Cheng Devrim Ersahin Indukala Doddamane |
| author_sort | David Cheng |
| collection | DOAJ |
| description | Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the possibility of assessing the uptake by the tumor prior to the therapy. Several different radiopharmaceuticals are currently being used by various administration routes and targeting mechanisms. This article aims to briefly review the current status of targeted radiotherapy as well as to outline the advantages and disadvantages of radionuclides used for this purpose. |
| first_indexed | 2024-03-12T10:59:04Z |
| format | Article |
| id | doaj.art-f07c065f9a0544969236757db1bd3f91 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T10:59:04Z |
| publishDate | 2011-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-f07c065f9a0544969236757db1bd3f912023-09-02T06:05:29ZengMDPI AGCancers2072-66942011-10-01343838385510.3390/cancers3043838Targeted Radionuclide TherapyDavid ChengDevrim ErsahinIndukala DoddamaneTargeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the possibility of assessing the uptake by the tumor prior to the therapy. Several different radiopharmaceuticals are currently being used by various administration routes and targeting mechanisms. This article aims to briefly review the current status of targeted radiotherapy as well as to outline the advantages and disadvantages of radionuclides used for this purpose.http://www.mdpi.com/2072-6694/3/4/3838/targeted radiotherapyradionuclideradioimmunotherapy |
| spellingShingle | David Cheng Devrim Ersahin Indukala Doddamane Targeted Radionuclide Therapy Cancers targeted radiotherapy radionuclide radioimmunotherapy |
| title | Targeted Radionuclide Therapy |
| title_full | Targeted Radionuclide Therapy |
| title_fullStr | Targeted Radionuclide Therapy |
| title_full_unstemmed | Targeted Radionuclide Therapy |
| title_short | Targeted Radionuclide Therapy |
| title_sort | targeted radionuclide therapy |
| topic | targeted radiotherapy radionuclide radioimmunotherapy |
| url | http://www.mdpi.com/2072-6694/3/4/3838/ |
| work_keys_str_mv | AT davidcheng targetedradionuclidetherapy AT devrimersahin targetedradionuclidetherapy AT indukaladoddamane targetedradionuclidetherapy |